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Abstract 34 
 2
Coenzyme Q (CoQ) is an essential cofactor, primarily found in the mitochondrial inner 35 
membrane where it functions as an electron carrier in the respiratory chain, and a lipophilic 36 
antioxidant. The redox state of the CoQ pool is the ratio of its oxidised (ubiquinone) and 37 
reduced (ubiquinol) forms, and is a key indicator of mitochondrial bioenergetic and 38 
antioxidant status. However, the role of CoQ redox state in vivo is poorly understood, 39 
because determining its value is technically challenging due to redox changes during 40 
isolation, extraction and analysis. To address these problems, we have developed a sensitive 41 
liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay that enables us to 42 
extract and analyse both the CoQ redox state and the magnitude of the CoQ pool with 43 
negligible changes to redox state from small amounts of tissue. This will enable the 44 
physiological and pathophysiological roles of the CoQ redox state to be investigated in vivo. 45 
 46 
Highlights  47 
• Sensitive LC-MS/MS assay to quantify CoQ redox state  48 
• Changes in CoQ redox state can be measured in mitochondria, cells and in vivo 49 
• CoQ redox state is stable during extraction and analysis 50 
 51 
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1. INTRODUCTION 57 
 58 
Coenzyme Q (CoQ) is a hydrophobic respiratory chain component within the mitochondrial 59 
inner membrane that is also found to a far lesser extent in other membranes [1] (Figure 1a). 60 
The final steps of CoQ biosynthesis take place in mitochondria, where the redox active 61 
benzoquinone headgroup is linked to an isoprenyl chain in which the number of isoprenoid 62 
units varies with species: in yeast it is CoQ6, in rodents it is mainly CoQ9 with some CoQ10, 63 
while in humans CoQ10 predominates over CoQ9 [1–5]. Within the mitochondrial inner 64 
membrane CoQ collects electrons from dehydrogenases, notably complexes I and II (Figure 65 
1a), during which the ubiquinone form, CoQ, undergoes two-electron reduction to ubiquinol 66 
(CoQH2) (Figure 1b). The CoQH2 is then reoxidised to CoQ at complex III to enable the 67 
respiratory chain to reduce O2 to water while pumping protons across the inner membrane to 68 
establish the protonmotive force (∆p) that drives ATP synthesis by oxidative phosphorylation 69 
[1,6] (Figure 1a). In addition to complexes I and II, a number of other dehydrogenases also 70 
feed electrons into the CoQ pool from diverse metabolic pathways [1,7] (Figure 1c). As well 71 
as its role in the respiratory chain, CoQH2 is also an important antioxidant within the 72 
mitochondrial inner membrane where it acts as a chain breaking antioxidant to prevent lipid 73 
peroxidation [1-5].  74 
Thus, the CoQ pool plays a central role in mitochondrial function and is the 75 
organelle’s principal point of contact with many other metabolic pathways. Consequently 76 
CoQ deficiency contributes to mitochondrial dysfunction, disease and ageing [8–10]. The 77 
redox state of the CoQ pool is the ratio of its oxidised (CoQ) and reduced (CoQH2) forms, 78 
and is a key indicator of mitochondrial bioenergetic and antioxidant status. The CoQ redox 79 
state alters dynamically in response to its relative rates of reduction by dehydrogenases and 80 
oxidation by complex III or by reactive oxygen species (ROS). Changes in the CoQ redox 81 
state are central to mitochondrial redox signalling in oxygen sensing [11] and inflammation 82 
[12,13] and also to the tissue damage associated with ischaemia reperfusion injury [14–16]. 83 
Therefore, the CoQ redox state is central to health and disease and measuring it in vivo is 84 
vital. 85 
While assessing the size of the CoQ pool in tissues in vivo is straightforward, 86 
measuring its redox state in vivo is technically challenging. This is mainly due to the 87 
difficulty of stabilising the redox state of the CoQ pool during isolation, extraction and 88 
analysis. In addition, for many analytical methods large amounts of material are required, 89 
limiting applicability. Methods based on liquid chromatography coupled to electrochemical 90 
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detection were used extensively in the past to investigate CoQ levels and the CoQ redox state 91 
in biological samples [17–20]. More recently several LC-MS/MS approaches for analysis of 92 
the CoQ redox state have been described [17–23]. In these protocols single-phase CoQ 93 
extraction with relatively polar alcohols such as methanol or propanol are used [17,20–23]. 94 
However, as the samples change redox state during isolation and storage, samples have to be 95 
analysed rapidly and in small batches. Recently, an improved protocol was developed for the 96 
determination of the CoQ redox state in tissues by extraction into non-polar hexane followed 97 
by analysis in acidified ethanol [18]. While this limits oxidation, separate standard curves 98 
were still required for the two redox states, with the CoQH2 standard curve being a potential 99 
limitation due to oxidation of CoQH2 standards distorting the CoQ redox state. Here we 100 
describe a simplified two-phase extraction that utilises a single internal standard (IS) that 101 
generates a stable extract in which both the redox state of the CoQ pool and its amount can be 102 
determined. This will facilitate the analysis of both in vitro and in vivo models and expand 103 
our understanding of the role of the CoQ pool in health and disease. 104 
 105 
 106 
2. RESULTS 107 
 108 
2.1 CoQ LC-MS/MS assay  109 
To establish CoQ
 
redox state
 
detection by LC-MS/MS, CoQ9/10, CoQ9/10H2 and d6-CoQ10 110 
internal standard (IS) were prepared (Figure 2a). Precursor scans of direct infusion of 111 
methanol/ammonium formate solutions of these compounds detected the H+ and NH4+ 112 
adducts that gave product ions at 197 m/z for both ubiquinone and ubiquinol, and at 203 m/z 113 
for the IS (Figure 2b). We chose to use NH4+ adducts for LC-MS/MS analysis as they were 114 
more abundant, presumably due to higher concentrations of NH4+ compared to H+ within the 115 
buffer and because for both redox forms the H+ adducts showed the same mass for CoQ9 and 116 
CoQ10, making CoQ redox state analysis impossible.  The proposed fragmentations 117 
mechanism is shown in Figure S1. LC-MS/MS analysis of pure samples of each compound 118 
showed that the CoQ and CoQH2 were detected in the appropriate channel (Figure 2c). While 119 
there was some bleed through of ubiquinone samples into the ubiquinol m/z channel, 120 
ubiquinone and ubiquinol were readily separated by LC (Figure 2c). Hence, this LC-MS/MS 121 
analysis can easily separate the two redox forms, despite a mass difference of only 2. 122 
 123 
2.2 CoQ redox state determination 124 
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To determine the redox state of the CoQ pool it would be most convenient to measure the 125 
ratio of the mass spectrometer response to the two redox forms, to avoid having to construct 126 
standard curves for both redox forms of CoQ9 and CoQ10. For this to work the relative mass 127 
spectrometer response to CoQ and CoQH2 must be stable over a range of concentrations and 128 
ratios of both forms. To see if this was the case, the peak areas following analysis of equal 129 
amounts of CoQ and CoQH2 at a range of increasing total concentrations were compared 130 
(Figure 3a). This analysis indicated that both redox forms of CoQ9 and CoQ10 had similar 131 
mass spectrometric responses. Furthermore, when samples containing a range of CoQH2/CoQ 132 
ratios were assessed the LC-MS/MS analysis also detected these ratios accurately (Figure 133 
3b). As the CoQH2/CoQ ratio also determines the % reduction of the CoQ pool, we replotted 134 
these data as % reduction (Figure 3c) and also the reduction potential for the CoQ/CoQH2 135 
redox couple [24] (Figure 3d). Of note, for CoQH2/CoQ ratios of 100:1, in contrast to ratios < 136 
50:1, the measured value did not match that of the input sample, indicating that at very low 137 
CoQ reduction potentials some CoQH2 oxidation will inevitably occur. However, these 138 
highly reduced ratios are beyond the biologically relevant range. These analyses showed that 139 
measurement of the uncorrected ratio of the mass spectrometric response to both redox forms 140 
enables simultaneous and accurate determination of the redox states of both the CoQ9 and 141 
CoQ10 pools. We also wanted to investigate if CoQH2 has the potential to transfer electrons to 142 
CoQ following extraction, and thereby distort the measured ratios. To do this we mixed 143 
CoQ9H2 and CoQ10, or CoQ10H2 and CoQ9, in methanol containing 2 mM ammonium formate 144 
and incubated for 2 hours at 37˚C (Figure S2a,b). This showed some slow oxidation of 145 
CoQH2, but this was not associated with direct reduction of the ubiquinone of the other 146 
species (Figure S2a,b). This analysis showed that the oxidation of the ubiquinols was slow 147 
under our conditions, even at 37˚C, and that this oxidation was not associated with 148 
ubiquinone reduction. Therefore, during cold storage of the extracts oxidation of CoQH2 will 149 
have minimal effect on the CoQH2/CoQ ratio. 150 
 151 
2.3 CoQ9 and CoQ10 quantification 152 
The above analysis showed that the CoQH2/CoQ redox ratio could be measured without the 153 
requirement for standard curves, simplifying the analysis and removing potential 154 
confounding factors of ubiquinol oxidation during standard curve preparation. However, it is 155 
also important to determine the sizes of the CoQ9 and CoQ10 pools. To do this we used d6-156 
CoQ10 as an IS which was synthesised by base-catalysed exchange of the methoxy groups of 157 
CoQ10 dissolved in hexane-CD3OD. This generated pure compound that could be used as an 158 
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internal standard. The two-stage preparation described previously [19] proved unnecessary. 159 
Using d6-CoQ10 as IS we constructed standard curves for CoQ9 and CoQ10 (Figure 4a,b). This 160 
enables the total amounts of CoQ9 and CoQ10 in a sample to be determined, in parallel with 161 
measurement of their redox ratios.  162 
 163 
2.4 Measurement of the CoQ redox state in mitochondria and cells 164 
Next, we extended the CoQ extraction method to the analysis of isolated mitochondria and 165 
cells. For bovine heart mitochondrial membranes and isolated rat heart mitochondria we used 166 
a two-phase extraction with ice-cold hexane and acidified methanol (Figure 5a). This 167 
precipitated proteins and retained many potential redox active polar metabolites in the 168 
aqueous-methanol phase, while acidification helped prevent oxidation of ubiquinol. Finally, 169 
extracting the CoQ pool into hexane generated a stable solution which was then processed for 170 
mass spectrometry.  171 
To assess the efficacy of this procedure we measured the CoQ redox state in bovine 172 
mitochondrial membranes, which contain predominantly CoQ10, respiring on NADH or 173 
succinate in the presence of various inhibitors (Figure 5b). Membranes respiring on NADH 174 
or succinate had a CoQ pool of about 56 – 60 % reduced. With NADH the complex I 175 
inhibitor rotenone decreased this to ~ 4% reduced (Figure 5c), while with succinate the 176 
complex II inhibitor malonate also maintained an oxidised CoQ pool of ~12% reduced 177 
(Figure 5d). Addition of the complex IV inhibitor KCN led the CoQ pool to be ~ 80 % 178 
reduced (Figure 5c,d). Incubating membranes at 37˚C in the absence of substrates led to 179 
complete oxidation of the CoQ pool, which can subsequently be reduced to ~ 60% by NADH 180 
(Figure 5e).  181 
We next examined isolated rat heart mitochondria, which contain mainly CoQ9. 182 
Mitochondria respiring on glutamate/malate to generate NADH led to reduction of the CoQ 183 
pool (Figure 5f). The CoQ pool was oxidised by blocking complex I with rotenone and 184 
increased to ~77% reduction upon addition of KCN. Using succinate as a substrate also led to 185 
CoQ reduction that was decreased by malonate and increased by KCN. Addition of the 186 
uncoupler FCCP to abolish ∆p and thereby stimulate respiration oxidised the CoQ pool 187 
(Figure 5g). 188 
To assess CoQ in a monolayer of C2C12 cells in culture we first rapidly washed the 189 
cell layer and then scraped the cells into cold PBS before extraction. As C2C12 cells are 190 
derived from mice, CoQ9 is the predominant form of CoQ. Cells showed a similar steady 191 
state CoQ redox state to isolated mitochondria, and this was oxidised by blocking complexes 192 
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I and II with rotenone and TTFA, respectively (Figure 5h). Uncoupling mitochondria with 193 
FCCP oxidises the CoQ pool due to increased respiration, and blocking complex III with 194 
antimycin led to reduction of the CoQ pool (Figure 5h).  195 
In all three systems, there was a dominant CoQ species, either CoQ9 or CoQ10, along 196 
with a far smaller amount of the other form. The redox state of the major form is reported 197 
above, but the method detected both forms accurately. In all cases the redox state of the 198 
major and minor CoQ species were the same, suggesting that both pools come to the same 199 
redox state (Figure S3a-f).  200 
 201 
2.5 Measurement of the CoQ redox state in vivo  202 
We next extended the two-phase extraction to assess CoQ redox state in vivo. To do this we 203 
focussed on the mouse heart and liver as these are important tissues in which the CoQ redox 204 
state is important in health and disease. In assessing tissues, it is vital to freeze the tissue as 205 
rapidly as possible so that the measured CoQ redox state accurately reflects that in vivo. To 206 
illustrate this, heart or liver tissue was excised either from terminally anaesthetised mice after 207 
thoracotomy, or after cervical dislocation and then rapidly frozen in a Wollenberger clamp at 208 
liquid nitrogen temperature. The frozen tissue was then homogenised in ice-cold acidified 209 
methanol and hexane and analysed by LC-MS/MS (Figure 6a).  210 
We first determined how well this procedure extracted CoQ from the tissue (Figure 211 
6b, S4a,b). This was done by re-extracting the heart and liver tissue and seeing how much 212 
residual CoQ was extracted (Figure 6b, S4a,b). This showed that the first extraction removed 213 
~75-80% of the CoQ pool. While subsequent extractions could remove a bit more, it was 214 
decided not to include a second extraction routinely.  215 
We next quantified the CoQ pool in heart and liver and found ~1.2 nmol CoQ9 and 216 
~0.12 nmol CoQ10 per mg protein in heart (Figure 6c). In the liver the CoQ pools are much 217 
smaller with ~250 pmol CoQ9 and ~6 pmol CoQ10 per mg protein (Figure 6c). These values 218 
are consistent with the previously reported values [25,26]. Interestingly the CoQ9/CoQ10 ratio 219 
varied significantly between organs, being ~10 in heart and ~42 in liver (Figure 6d).  220 
An important constraint in analysing the CoQ redox state is the oxidation of extracts 221 
by air before analysis. This often requires the rapid analysis of sample which are processed in 222 
small batches. To see if this was a concern, we reanalysed the CoQ redox state of samples 223 
stored in the LC-MS/MS autosampler at 8˚C for up to 24 hours in argon-flushed tubes. The 224 
CoQ redox state was stable for at least 24 hours in the autosampler, confirming that large 225 
sample sets can be analysed in one run without artefactual oxidation (Figure 6e, S4c). The 226 
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CoQ redox state was stable without argon flushing (Figure S4d). Nevertheless, we continued 227 
to flush samples with argon as a precaution. We next investigated the stability of the CoQ 228 
redox state of extracts during long-term storage at -20˚C in argon-flushed tubes. This showed 229 
that the CoQ redox state was stable upon storage for up to at least 65 days (Figure 6f). This 230 
allows to store and combine separate CoQ extractions in a single analysis run.  231 
We noticed that CoQ extracts from mouse hearts were far more reduced than 232 
previously reported values (Figure 6e) [18]. Consequently, we wanted to assess whether there 233 
was any artifactual reduction of CoQ during extraction. To do this we set up a detection 234 
protocol for d6-CoQ10 and d6CoQ10H2 as described in section 2.1 (Figure S4e,f). We then 235 
measured the reduction of d6-CoQ10 when it was spiked into the tissue extraction solution and 236 
detected ~6% of the added d6-CoQ10 as d6-CoQ10H2 in our extracts (Figure S4g). In a mock 237 
extraction without tissue ~0.8% of the added d6-CoQ10 was converted to d6-CoQ10H2. No 238 
signal for d6-CoQ10 or d6-CoQ10H2 was detected in unspiked tissue extracts (Figure S4g). 239 
Therefore, we conclude that a small amount of CoQ reduction can occur during extraction. 240 
However, completely oxidised d6-CoQ10 is thermodynamically much more prone to reduction 241 
than the already largely reduced CoQ pools found in vivo and even if the oxidized CoQ pool 242 
was underestimated by 5% this would have a minor effect on the overall redox state.  243 
Next, we wanted to determine the CoQ redox state in clamp frozen heart. In mice 244 
killed by cervical dislocation the CoQ pool was highly reduced at 89% and remained at a 245 
similar redox state even after 30 minutes of warm ischaemia (Figure 6g, S5a). To explore 246 
whether the tissue collection time from cervical dislocation to clamp-freezing has an effect on 247 
CoQ redox state, we next assessed the level of CoQ redox state in hearts obtained from 248 
terminally anaesthetized mice. In these mice the heart was excised directly after chest 249 
opening. This enabled a still-beating heart to be rapidly frozen and clamped. This gave a 250 
CoQH2 % reduction of 85% (Fig S5b), similar to that from hearts excised from animals after 251 
cervical dislocation. The redox state of the CoQ10 pool was also similar indicating that, as 252 
mentioned above, the two CoQ pools are bioenergetically equivalent (Fig 6g, S5a,b). The 253 
CoQ pool can be fully oxidised by homogenizing the heart in buffer and incubation at 37˚C 254 
for 1 hr (Figure 6h, S5c). We also determined the CoQ redox state in freshly excised and 255 
ischaemic liver and found it to be highly reduced at 92% (Figure 6i, S5d). As in the heart we 256 
also did not observe any significant changes in the CoQ redox state during ischaemia in liver 257 
(Figure 6i, S5d). For all tested tissues the LC-MS/MS traces were clean and the retention 258 
times of the individual CoQ species matched those of pure CoQ (Figure S5e). 259 
 260 
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3. CONCLUSIONS 261 
 262 
Changes in the CoQ redox state have broad implications in the regulation of metabolic 263 
processes, respiration and mitochondrial ROS production. The difficulty in determining the 264 
CoQ redox state in biological samples and in vivo have been a significant impediment for the 265 
characterisation of CoQ function within mitochondria under physiological and 266 
pathophysiological conditions. Here we have developed a sensitive and comparable approach 267 
to assess the CoQ redox state by LC-MS in isolated mitochondria, cells and tissues. Applying 268 
this approach, we are able to detect CoQ and CoQH2 at equal sensitivity, allowing relative 269 
quantification without the need for a range of internal standards, an improvement on previous 270 
methods, which used standard curves for both CoQ and CoQH2. In parallel, the total CoQ 271 
pool size can be determined using only a standard curve of oxidised CoQ. In contrast to 272 
related approaches [18], we found that while the redox states of CoQ9 and CoQ10 can be 273 
manipulated with inhibitors and uncouplers they were essentially the same during normal 274 
conditions in a range of systems. Furthermore, we found that the CoQ redox state is highly 275 
(~90%) reduced in tissues in vivo, something that was not found in other studies, perhaps due 276 
to oxidation of the CoQ pool during extraction and processing [18]. Thus our method enables 277 
the redox state of the CoQ pool in vivo to be determined more accurately than hitherto. Our 278 
protocol opens up new possibilities to unravel the role of the CoQ redox state in vivo to 279 
understand the interplay between metabolism and bioenergetics in physiological and 280 
pathophysiological processes. 281 
 282 
4. MATERIALS AND METHODS  283 
 284 
4.1 Materials 285 
All chemicals were purchased from Sigma unless otherwise stated. LC-MS grade Methanol 286 
was purchased from Fisher. All buffers, except LC-MS buffers, were stored over Chelex-100.  287 
Acidified solvents were prepared by addition of 0.1% (w/v) HCl. 288 
 289 
4.2 Synthesis of d6-CoQ10  290 
Sodium hydroxide (400 µL, 1 M in CD3OD) was added to a solution of CoQ10 (400 mg, 0.46 291 
mmol, 1.0 eq) in hexane (5 mL) and d4-MeOD (4 mL). The solution was stirred at RT for 6 h 292 
then quenched with acetic acid. The solution was extracted into diethyl ether (~20 mL), 293 
washed with brine (2 × 75 mL), dried over sodium sulfate and concentrated under vacuum. 294 
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The residue was purified by automated column chromatography using a 25g SNAP ultra 295 
cartridge on a Biotage Isolera using gradient elution from CH2Cl2:Hexane (0:100) to (80:20). 296 
The product was recrystallised from isopropanol-diethyl ether to give the labelled CoQ10 as 297 
an orange solid (162 mg, 40%). δH (400 MHz: CDCl3): 5.13-5.04 (9H, m, 9 × CH=), 4.94 298 
(1H, tq, J = 7.1 + 1.4 Hz, CH=), 3.18 (2H, d, J = 7.0 Hz, CH2), 2.10-2.03 (16H, m, 8 × CH2), 299 
2.01 (3H, s, CH3), 2.00-1.93 (20H, m, 10 × CH2), 1.74 (3H, s, CH3), 1.68 (3H, s, CH3), 1.60 300 
(21H, broad s, 7 × CH3), 1.58 (3H, s, CH3). m/z (ESI): Found: 891.7120. C59H84D6NaO4 301 
requires (M+Na) +, 891.7108. 302 
 303 
4.3 Calculation of CoQ reduction potential  304 
The CoQ reduction potential was calculated using the following equation, assuming a matrix 305 
pH of 7.7 [24]. Eh for the CoQ/CoQH2 couple in mV is: 306 
  	 = −38 + 30.5(

) 
 307 
4.4 Preparation of mitochondria and mitochondrial membranes  308 
Bovine heart mitochondrial membranes were kindly provided by Dr Hiran Prag and Prof 309 
Judy Hirst (MRC MBU) and were prepared as described previously [27]. Female Wistar rats 310 
(Charles River) of 10-12 weeks of age were killed by stunning, followed by cervical 311 
dislocation. Rat hearts were homogenized in STEB (250 mM sucrose, 5 mM Tris-HCl, 1 mM 312 
EGTA, 0.1% fatty acid free BSA, pH 7.4, 4˚C). Mitochondria were isolated by differential 313 
centrifugation (2x 700 x g for 5 min, 2 x 5.500 x g for 10 min) at 4˚C and the protein content 314 
was determined by the bicinchoninic acid assay using the PierceTM BCA Protein assay kit 315 
with bovine serum albumin as a standard. 316 
 317 
4.5 Mouse heart and liver experiments 318 
All mouse experiments were carried out in accordance with the UK Animals (Scientific 319 
Procedures) Act 1986 and the University of Cambridge Animal Welfare policy (Project 320 
license 70/8238). Male mice (8-10 weeks; C57BL/6J; Charles River Laboratories) were 321 
terminally anaesthetized with sodium pentobarbital injected intraperitoneally and ventilated 322 
with O2. Core temperature was monitored continuously via a rectal probe. Alternatively, mice 323 
were culled by cervical dislocation. A sternal thoracotomy was performed (heart) or the 324 
abdomen was opened (liver) and the organ was rapidly excised and then frozen with a 325 
Wollenberger clamp cooled in liquid nitrogen followed by storage at -70°C. Ischaemia was 326 
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induced by excising the organ and keeping it in the abdomen or chest of the warmed mouse 327 
for indicated lengths. Organs were then frozen and stored as described. 328 
 329 
4.6 Reduction of ubiquinone  330 
Ubiquinones (CoQ9, CoQ10 and d6-CoQ10) were reduced to ubiquinols using sodium 331 
borohydride. All glassware was rinsed in hexane and dried under nitrogen before use. CoQ9 332 
or CoQ10 were made up to 10 mM in hexane, then diluted 1:10 in hexane. Solid sodium 333 
borohydride was added (2 mg/ 100 µl) to the CoQ dilution followed by addition of methanol 334 
(to 5% v/v), vortexing for 3 min and incubation in the dark for 5 min. The reaction was 335 
stopped by addition of 1 vol. acidified H2O with vortexing for 1 min followed by 336 
centrifugation (1500 x g, 5 min at 4˚C). The CoQ-containing upper hexane layer was 337 
transferred to a glass vial, overlaid with argon and stored at -20˚C. UV scanning spectra 338 
confirmed reduction and enabled the concentration to be calculated: ε290 = 4.1 mM-1cm-1 339 
(CoQ9H2), 4.0 mM-1cm-1 (CoQ10H2); ε275 = 14.7 mM-1cm-1 (CoQ9), 14.6 mM-1cm-1 (CoQ10) 340 
[28]. 341 
 342 
4.7 Mass spectrometry 343 
The mass spectrometric fragmentation patterns for the ammonium adducts of each CoQ 344 
CoQH2 compound were determined by direct infusion of 10 µM of the compound in 2 mM 345 
ammonium formate in methanol at 2 µl/min into a triple quadrupole mass spectrometer 346 
(Waters Xevo TQ-S). Electrospray ionisation in positive ion mode was used as published 347 
previously with the following settings [29]: capillary voltage – 1.7 kV; cone voltage – 30 V; 348 
ion source temperature – 100˚C; collision energy – 22 V. Nitrogen and argon were used as 349 
the curtain and the collision gases, respectively.  350 
 351 
4.8 Liquid chromatography tandem mass spectrometry  352 
LC-MS/MS analyses were carried out using an I-Class Acquity LC system attached to a 353 
Xevo TQ-S triple quadrupole mass spectrometer (Waters) using published parameters [29]. 354 
Samples were kept at 8˚C prior to injection by the autosampler of 2-10 µl into a 15 µl flow-355 
through needle and RP-HPLC at 45˚C using an Acquity C18 column (2.1x50 mm, 1.7 µM; 356 
Waters). Mobile phase was isocratic 2 mM ammonium formate in methanol run at 0.8 ml/min 357 
over 5 min. For MS analysis, electrospray ionization in positive ion mode was used as 358 
described above. Multiple reaction monitoring in positive ion mode was used for compound 359 
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detection. Transitions used for quantification were: CoQ9, 812.9 > 197.2; CoQ10, 880.9 > 360 
197.2; CoQ9H2, 814.9 > 197.2; CoQ10H2, 882.9 > 197.2; d6-CoQ10, 887.0 > 203.1; d6-361 
CoQ10H2, 889.0 > 203.1. Standard curves were prepared using known amounts of CoQ, 362 
which were spiked with d6-CoQ10 (IS). Standards and samples were quantified using 363 
MassLynx 4.1 software to determine the peak area for CoQ9, CoQ10, CoQ9H2, CoQ10H2, d6-364 
CoQ10 and d6-CoQ10H2, and the standard curves used to determine the total amount of CoQ 365 
present in samples. 366 
 367 
4.9 Mitochondrial Incubations  368 
Mitochondrial membrane or rat heart mitochondria were incubated at 15 µg protein in 100 µl 369 
KPi buffer (50 mM KPi, pH 7.8) or KCl buffer (120 mM KCl, 10 mM HEPES, 1 mM EGTA. 370 
pH 7.2), respectively. Substrates and inhibitors were added at the following concentrations 371 
where indicated: 1 mM NADH, 1 mM succinate, 1 mM glutamate/malate, 0.5 µM carbonyl 372 
cyanide-p-trifluoromethoxyphenylhydrazone (FCCP), 0.5 µM rotenone, 1 mM malonate, 1 373 
mM KCN. Samples were incubated with shaking for 5 min or 20 min at 37˚C.  374 
 375 
4.10 Cell incubations 376 
C2C12 mouse myoblast cells (ATCC, UK) were cultured at 37˚C under a humidified 377 
atmosphere of 5% CO2 in Dulbecco’s modified Eagles’s medium (DMEM/4.5 g/l glucose + 378 
GlutaMAX, Gibco, UK) supplemented with 10% fetal bovine serum, 100 units/ml penicillin 379 
and 100mg/ml streptomycin. Cells (100,000) were plated 24 hrs prior to experiment in 6-well 380 
plates with 2 ml medium. For experiments inhibitors were added at the following 381 
concentrations: 1 µM rotenone, 1 mM theonoyltrifluoroacetone (TTFA), 5 µM FCCP, 5 µM 382 
Antimycin A. Cells were then incubated for 5 min at 37˚C, washed with PBS and scraped in 383 
200 µl fresh PBS on ice prior to CoQ extraction. 384 
 385 
4.11 CoQ extraction  386 
To extract CoQ from mitochondrial membranes and mitochondria, incubations of 100 µl 387 
containing 15 µg protein were added to ice cold extraction solution (200 µl acidified 388 
methanol and 200 µl hexane) followed by vortexing. To extract CoQ from cells, the cell 389 
suspension in 200 µl PBS was transferred to ice cold extraction solution (200 µl acidified 390 
methanol and 300 µl of hexane) followed by vortexing. To extract CoQ from tissues, 5 mg 391 
frozen tissue was weighed into cooled lysis tubes (Precellys, CK-14) on dry ice. Then a 392 
mixture of 250 µl ice-cold acidified methanol and 250 µl hexane was added, and tissue was 393 
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homogenised in the bullet blender (Bertin Instruments, Precellys 24) at setting 6500 during 394 
15 seconds (CK14 (1.4 mm) beads). The homogenate was transferred to fresh 1.5 ml 395 
Eppendorf tubes. In all cases the upper, CoQ-containing hexane layer was separated by 396 
centrifugation (5 min, 17,000 x g, 4˚C) and then dried down in 1 ml glass mass spectrometry 397 
vials (186005663CV, Waters) under a stream of N2. Dried samples were then resuspended in 398 
methanol containing 2 mM ammonium formate and diluted (heart 1:10, liver not dilution: 399 
CoQ10 or 1:3 dilution CoQ9), overlaid with argon and stored at -20˚C until analysis. The 400 
extracts were stable under storage for up to at least 15 days.  401 
 402 
4.12 CoQ extraction for CoQ pool size determination 403 
To extract CoQ from tissues, 5 mg frozen tissue was weighed into cooled lysis tubes 404 
(Precellys, CK-14) on dry ice. Then 150 µl KPi buffer (50 mM KPi, pH 7.8) was added and 405 
tissue was homogenised in the bullet blender (Bertin Instruments, Precellys 24) at setting 406 
6500 during 15 seconds (CK14 (1.4 mm) beads). CoQ was extracted from 100 µl of the 407 
homogenate by adding a mixture of 250 µl ice-cold acidified methanol and 250 µl hexane 408 
and vortexing. The upper, CoQ-containing hexane layer was separated by centrifugation (5 409 
min, 17,000 x g, 4˚C) and then dried down in 1 ml glass mass spectrometry vials 410 
(186005663CV, Waters) under a stream of N2. Dried samples were then resuspended in 411 
methanol containing 2 mM ammonium formate. Heart tissue was diluted 1:10 (20 µl in 170 412 
µl methanol containing 2 mM ammonium formate and 10 µl of 5 µM d6-CoQ10 internal 413 
standard), while liver homogenate was either not diluted (CoQ10 analysis) or diluted 1:3 414 
(CoQ9 analysis). Samples were overlaid with argon and stored at -20˚C until analysis.  415 
 416 
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∆p mitochondrial protonmotive force 
CoQ10 coenzyme Q10 
CoQ10H2 reduced Q10 
CoQ9 coenzyme Q9 
CoQ9H2 reduced Q9 
ETC electron transfer chain 
IS internal standard 
LC-MS/MS liquid chromatography tandem mass spectrometry 
MRM multiple reaction monitoring 
RET reverse electron transfer 
ROS reactive oxygen species 
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FIGURE LEGENDS 556 
 557 
Figure 1: The CoQ pool in the mitochondrial inner membrane as essential link between 558 
metabolic pathways and cellular energy supply.  559 
Various mitochondrial enzymes of diverse metabolic function feed electrons into the CoQ 560 
pool of the inner mitochondrial membrane. The electrons are then relayed to complex III of 561 
the ETC and thereby coupled to the maintenance of ∆p and ATP production. a Complex I 562 
(NADH:Ubiquinone oxidoreductase) and complex II (succinate dehydrogenase) of the ETC 563 
chain are the canonical enzymes feeding electrons into the CoQ pool under normal 564 
conditions. The electrons are shuttled to complex III (ubiquinol:cytochrome c 565 
oxidoreductase) to be transferred onto cytochrome c and finally oxidised by complex IV 566 
(cytochrome c oxidase). By pumping protons from the matrix into the intermembrane space, 567 
complexes I, III & IV establish the mitochondrial protonmotive force (∆p), which is used for 568 
ATP synthesis by complex V (ATP-synthase) and various transport processes across the 569 
inner membrane. b The two electron carrier ubiquinone is a 1,4-benzoquinone, linked to an 570 
isoprene tail which in mammals consists of 9-10 isoprenyl subunits. Ubiquinone is reduced to 571 
ubiquinol by two electrons and acts as electron shuttle and antioxidant. c Numerous other 572 
mitochondrial oxidoreductases, such as SQR (hydrogen sulfide:ubiquinone oxidoreductase, 573 
catabolism of hydrogen sulphide), DHODH (dihydroorotate dehydrogenase, pyrimidine 574 
biosynthesis), CHDH (choline dehydrogenase, choline oxidation), G3PDH (glycerol 3-575 
phosphate dehydrogenase, glycerol-3-phosphate shuttle), ETF-QO (electron-transferring-576 
flavoprotein dehydrogenase, fatty acid oxidation) and PRODH (proline dehydrogenase, 577 
catabolism of proline) feed electrons into the mitochondrial CoQ pool. The electrons are 578 
funnelled by CoQ via complex III and cytochrome c to complex IV to reduce O2 to H2O.  579 
 580 
Figure 2: Method development for the detection of CoQ9/10 and CoQ9/10H2 by LC-MS/MS 581 
a The absorbance CoQ9 and CoQ10 were characterised by spectral scanning before and after 582 
reduction with NaBrH4. Upon reduction, the characteristic absorption maximum shifts from 583 
275 to 290 nm. b Representative precursor and product MS scans of CoQ9 and CoQ10 stocks 584 
and their reduced forms as well as the deuterated d6-CoQ10 internal standard. Precursor scans 585 
of the characteristic fragment products were performed. The product scans were performed 586 
by fragmenting the ammonium adduct precursors. Upon fragmentation the CoQ precursor 587 
loses its isoprene side chain and forms a tropylium ion. c Representative LC-MS/MS 588 
chromatograms showing the m/z transitions measured simultaneously for 0.5 pmol of CoQ9, 589 
 20 
CoQ10, CoQ9H2, CoQ10H2 and d6-CoQ10. Traces are normalised to the highest peak for each 590 
sample. CoQ9 and CoQ10 show bleed through into the transitions for CoQ9H2 and CoQ10H2, 591 
respectively. Bleed through of the CoQ9 and CoQ10 signals has been projected in red onto the 592 
CoQ9H2 and CoQ10H2 traces to show they are separated by LC.  593 
 594 
Figure 3: Determining and quantifying the ratio of CoQ and CoQH2 by LC-MS/MS 595 
To validate the quantification of oxidised and reduced CoQ, CoQ9/10 and borohydride 596 
reduced CoQ9/10H2 stocks were mixed in predetermined ratios and measured by LC-MS/MS. 597 
a Detected peak areas of increasing amounts of CoQH2 and CoQ mixed in a 1:1 ratio. b The 598 
detected CoQH2/CoQ ratios were blotted against the expected theoretical CoQH2/CoQ ratios. 599 
c The proportion of CoQH2 was blotted against the expected theoretical CoQH2/CoQ ratios. d 600 
The redox potential of CoQH2/CoQ mixtures was calculated based on the detected 601 
CoQH2/CoQ ratios and was blotted against the expected theoretical CoQH2/CoQ ratios. The 602 
calculations are outlined in the methods section. Data are mean ± S.D. of 3 replicates. 603 
 604 
Figure 4: Standard curve for the quantification of the CoQ pool size by LC-MS/MS 605 
Representative standard curve or oxidised CoQ9 (a) and CoQ10 (b). The MS response of 606 
increasing concentrations of CoQ9 and CoQ10 was compared to 0.5 pmol of d6-CoQ10 607 
(internal standard, IS). Data are mean ± S.D. of 3 replicates. The grey-shaded section of the 608 
standard curve on the left is expanded and replotted in the right panel. 609 
 610 
Figure 5: Extracting CoQ from biological samples and modifying the CoQ redox state in 611 
mitochondrial membranes, mitochondria and cells 612 
a A two-phase extraction with acidified methanol and hexane was used to extract CoQ from 613 
bovine mitochondrial membranes, mitochondria and cells. CoQ from incubations of 614 
biological samples was extracted by vortexing in extraction solution, phase separation by 615 
centrifugation and resuspending the extract in MS sample buffer (methanol with 2 mM 616 
ammonium formate). b Various inhibitors can be used to manipulate the mitochondrial CoQ 617 
redox state in biological samples. c-h Bovine heart mitochondrial membranes (BHMM), rat 618 
heart mitochondria (RHM) and C2C12 cells were incubated in KPi (BHMM), KCl (RHM) 619 
buffer or DMEM (cells) and different combinations of substrates and inhibitors were added 620 
before CoQ extraction and LC-MS/MS analysis of the CoQ redox state. All incubations were 621 
performed for 5 minutes at 37˚C except otherwise indicated. CoQ redox state of: c BHMM 622 
 21 
incubated with NADH or NADH combined with rotenone or KCN. d BHMM incubated with 623 
succinate or succinate combined with malonate or KCN. e BHMM incubated for 20 min at 624 
37˚C. NADH or rotenone + NADH was added to indicated samples after 15 minutes. f RHM 625 
incubated with glutamate + malate (GM) or GM combined with rotenone or KCN. g RHM 626 
incubated with succinate or succinate combined with malonate, FCCP or KCN. h C2C12 627 
cells incubated in standard DMEM with FCCP, rotenone, TTFA or Antimycin A. 628 
For all experiments, data are represented as mean ± S.D. of 3 replicates. The proportion of 629 
CoQH2 is shown for the indicated most prevalent CoQ species. 630 
 631 
Figure 6: Extracting CoQ from tissues and determining the CoQ redox state 632 
a A two-phase extraction with acidified methanol and hexane was used to extract CoQ from 633 
tissues. CoQ from clamp frozen tissue samples was extracted by homogenising in extraction 634 
solution, phase separation by centrifugation and resuspending the extract in MS sample 635 
buffer (methanol with 2 mM ammonium formate). b CoQ was extracted from mouse heart 636 
and liver tissue homogenates and the tissue homogenate was then reextracted. The peak areas 637 
for CoQ and CoQH2 were combined and the cumulative proportion combined with all 638 
previous extractions of the total is shown. Data are shown as mean ± S.D. of 6 different 639 
samples from 3 different animals. c The CoQ pool size of CoQ9 and CoQ10 in mouse heart 640 
and liver. Data are shown as mean ± S.D. of 6 different samples from 3 different animals. d 641 
The CoQ9/CoQ10 ratio in mouse heart and liver. Data are shown as mean ± S.D. of 6 different 642 
samples from 3 different animals. e CoQ redox state changes over time (at 8˚C) during 643 
several consecutive LC-MS runs (~80 min per run per sample set; final run at 24 hours) in 644 
CoQ extracts of control and ischaemic mouse hearts. The proportion of CoQH2 is represented 645 
as mean ± S.D. of 3 different hearts. f CoQ redox state changes during long term storage for 646 
up to 65 days (at -20˚C) in CoQ extracts of control mouse hearts. The proportion of CoQH2 is 647 
represented as mean ± S.D. of 3 different hearts. g CoQ redox state of control and ischaemic 648 
mouse heart. The proportion of CoQH2 is represented as mean ± S.D. of 3 different hearts. h 649 
CoQ redox state of mouse heart tissue and tissue homogenates of the same hearts, after 650 
oxidising the CoQ pool in KPi buffer for 1 hr at 37˚C. The proportion of CoQH2 is 651 
represented as mean ± S.D. of 3 different hearts. i CoQ redox state of control and ischaemic 652 
(10 and 30 min) mouse liver. The proportion of CoQH2 is represented as mean ± S.D. of 3 653 
different livers. 654 
 
 
 
 
 
 
Highlights  
• Sensitive LC-MS/MS assay to quantify CoQ redox state  
• Changes in CoQ redox state can be measured in mitochondria, cells and in vivo 
• CoQ redox state is stable during extraction and analysis 
 
